TAB1

TAB1

Target · Signalling adapter protein

TAB1 TGF-beta activated kinase 1 (MAP3K7) binding protein 1 · MAP3K7IP1

TAB1 (TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, also known as MAP3K7IP1) is a key adapter protein that activates the kinase MAP3K7/TAK1 and MAPK14. It supports JNK and NF-kappa-B activation and proinflammatory cytokine production downstream of TLRs and cytokines. Browse Assay Genie's current range of TAB1 research reagents below, or read on for the biology behind the target.

Cytosol and ER membraneTAK1 and p38 activatorFeedback-regulated by MAPK14
504 aa
Protein length
~55 kDa
Molecular weight
22q13.1
Gene locus
Adapter protein
Protein class
Target information

What is TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1)?

TAB1 is an adapter protein with an essential role in JNK and NF-kappa-B activation and in the production of proinflammatory cytokines after stimulation of TLRs and cytokine receptors. It associates with the catalytic domain of MAP3K7/TAK1, which triggers TAK1 autophosphorylation and leads to its full activation. TAB1 also associates with MAPK14 (p38alpha) and triggers its autophosphorylation and subsequent activation, providing an alternative route to the classical MAPKK pathways.

The relationship is regulated by feedback. Once activated, MAPK14 phosphorylates TAB1 and inhibits TAK1 activation. TAB1 also helps recruit MAPK14 to the TAK1 complex, where MAPK14 phosphorylates the regulatory subunits TAB2 and TAB3. According to the NCBI Gene summary, the C-terminal portion of the protein is sufficient to bind and activate TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF-beta signalling. This suggests that TAB1 may mediate between TGF-beta receptors and TAK1.

The TAB1 gene encodes a protein found in the cytosol and at the endoplasmic reticulum membrane. TAK1 mediates signalling pathways induced by TGF-beta, interleukin 1 and WNT-1, and TAB1 was first identified as a regulator of this kinase. Alternatively spliced transcript variants encoding distinct isoforms have been reported. Previous names include mitogen-activated protein kinase kinase kinase 7 interacting protein 1, and the mouse ortholog is Tab1.

Innate immune signalling

TAB1 supports JNK and NF-kappa-B activation and proinflammatory cytokine production in response to TLR and cytokine stimulation.

TAK1 complex biology

TAB1 binds the TAK1 catalytic domain to trigger autophosphorylation, making it central to studies of TAK1 activation and its TAB2 and TAB3 subunits.

p38 MAPK regulation

TAB1 binds MAPK14 and triggers its autophosphorylation, offering an alternative activation route alongside the MAPKK pathways.

TGF-beta pathway research

The N-terminus of TAB1 can act as a dominant-negative inhibitor of TGF-beta, suggesting a link between TGF-beta receptors and TAK1.

Background

TAB1 frequently asked questions

What does TAB1 do?

TAB1 is an adapter protein that binds the catalytic domain of MAP3K7/TAK1 and triggers its autophosphorylation and full activation. It also binds and activates MAPK14. Through these kinases it contributes to JNK and NF-kappa-B activation and proinflammatory cytokine production.

What other names does TAB1 go by?

The HGNC name is TGF-beta activated kinase 1 (MAP3K7) binding protein 1, and the previous symbol is MAP3K7IP1. Older names include mitogen-activated protein kinase kinase kinase 7 interacting protein 1. Alternatively spliced transcript variants encoding distinct isoforms have been reported.

Is TAB1 conserved in other species?

A mouse ortholog, Tab1, is recorded for the human TAB1 gene, so rodent models can be used to study the pathway. No rat ortholog is listed in the data used here. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other regulatory subunits of the TAK1 complex that operate in the same signalling pathways.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15750; product specifications from Assay Genie datasheets.

TAB1 Product listing